Email this article 
THE FIRST EXPERIENCE WITH INGARON TREATMENT FOR CONJUNCTIVAL MELANOMA
- Authors: Brovkina A.F.1, Grishina Y.Y.1, Yatsenko O.Y.1, Andreichenko A.M.1
-
Affiliations:
- Russian Medical Academy of Postgraduate Education, Moscow
- Issue: Vol 2, No 2 (2012)
- Pages: 9-12
- Section: OPHTHALMOONCOLOGY
- Published: 15.04.2012
- URL: https://ogsh.abvpress.ru/jour/article/view/54
- DOI: https://doi.org/10.17650/2222-1468-2012-0-2-9-12
- ID: 54
Cite item
Abstract
The paper describes the first experience with the Russian drug Ingaron from an interferon-group in the treatment of patients with conjunctival melanoma. The positive result obtained during 5-to-62-month follow-ups allows its therapeutic action to be positively appreciated.
Keywords
About the authors
A. F. Brovkina
Russian Medical Academy of Postgraduate Education, Moscow
Author for correspondence.
Email: anab@list.ru
Russian Federation
Ye. Ye. Grishina
Russian Medical Academy of Postgraduate Education, Moscow
Email: fake@neicon.ru
Russian Federation
O. Yu. Yatsenko
Russian Medical Academy of Postgraduate Education, Moscow
Email: fake@neicon.ru
Russian Federation
A. M. Andreichenko
Russian Medical Academy of Postgraduate Education, Moscow
Email: fake@neicon.ru
Russian Federation
References
Supplementary files
